101 machine-learning-"https:" "https:" "https:" "https:" "https:" "UCL" "UCL" "UCL" positions at KU LEUVEN
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
machine learning You have good programming skills in Matlab, Python You have proven your proficiency in English language equivalent to B2 level You are enthusiastic and result oriented You can work
-
signal processing and machine learning algorithms, have strong interpersonal skills and the ability to work in an international team. Experience in wireless communication and networking fundamentals is a
-
research team. You are resilient under pressure and eager to learn. You have an excellent command of English, with a preference for candidates that also can speak and write in Dutch. Knowledge of additional
-
activities, I have gathered experience with machine/deep learning, and can demonstrate a strong affinity with these fields. Prior experience with computer vision is a plus. I am proficient in Python and am
-
well connected to the machine and transportation, high precisionindustriesand I am eager to learn how academic research can be linked to industrial innovation roadmaps. During my PhD I want to grow
-
: inge.vanhulle@kuleuven.be or Prof. dr. Wouter Druwé, mail: wouter.druwe@kuleuven.be .In case of problems with the online application, please contact solliciteren@kuleuven.be . Where to apply Website https
-
are eager to learn new techniques or methods · You work independently and accurately · You have demonstrated verbal and written communication skills in English · You are
-
information, please contact Prof. Ruth Heying, tel.: +3216340638, mail: ruth.heying@uzleuven.be or Prof. Sarah Thomis, mail: sarah.thomis@uzleuven.be Where to apply Website https://www.kuleuven.be/personeel
-
manipulation of fear and reward learning. This position is part of a recently funded, large-scale and innovative research program, aimed at creating new treatments for negative symptoms, among the most
-
manipulation of fear and reward learning. This position is part of a recently funded, large-scale and innovative research program, aimed at creating new treatments for negative symptoms, among the most